EGR2 anticorps (C-Term)

N° du produit ABIN2792631

Détail du produit anti-EGR2 anticorps

Antigène: EGR2 (Early Growth Response 2 (EGR2))

Épitope: C-Term

Reactivité: Humain, Souris, Rat, Porc, Cheval, Lapin, Boeuf (Vache), Chien

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EGR2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Séquence: PFACDYCGRK FARSDERKRH TKIHLRQKER KSSAPSASVP APSTASCSGG

Réactivité croisée: Chien, Humain, Souris, Porc, Rat (Rattus)

Homologie: Cow: 100%, Dog: 92%, Horse: 85%, Human: 100%, Mouse: 100%, Pig: 92%, Rabbit: 92%, Rat: 92%

Attributs du produit: This is a rabbit polyclonal antibody against EGR2. It was validated on Western Blot and immunohistochemistry.

Purification: Affinity Purified

Immunogène: The immunogen is a synthetic peptide directed towards the C terminal region of human EGR2

Information d'application

Indications d'application: WB Suggested Anti-EGR2 Antibody Titration: 0.2-1 µg/mL
ELISA Titer: 1:312500
Positive Control: Human Lung.
Optimal working dilutions should be determined experimentally by the investigator.

Commentaires:

Antigen size: 476 AA

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze-thaw cycles.

Stock: -20 °C

Stockage commentaire: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Références pour anticorps anti-EGR2 (ABIN2792631)

Damm, Mylonas, Cosson, Yoshida, Della Valle, Mouly, Diop, Scourzic, Shiraishi, Chiba, Tanaka, Miyano, Kikushige, Davi, Lambert, Gautheret, Merle-Béral, Sutton, Dessen, Solary, Akashi, Vainchenker et al.: "Acquired initiating mutations in early hematopoietic cells of CLL patients. ..." dans: Cancer discovery, Vol. 4, Issue 9, pp. 1088-101, (2014) (PubMed).

Lagrange, Martin, Droin, Aucagne, Paggetti, Largeot, Itzykson, Solary, Delva, Bastie: "A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages." dans: Biochimica et biophysica acta, Vol. 1833, Issue 8, pp. 1936-46, (2013) (PubMed).

Latasa, Ituero, Moran-Gonzalez, Aranda, Cosgaya: "Retinoic acid regulates myelin formation in the peripheral nervous system." dans: Glia, Vol. 58, Issue 12, pp. 1451-64, (2010) (PubMed).

Détails sur EGR2

Antigène: EGR2 (Early Growth Response 2 (EGR2))

Autre désignation: EGR2 (EGR2 Produits)

Sujet: The early growth response protein 2 (EGR2) is a transcription factor with three tandem C2H2-type zinc fingers. Mutations in this gene are associated with the autosomal dominant Charcot-Marie-Tooth disease, type 1.The early growth response protein 2 is a transcription factor with three tandem C2H2-type zinc fingers. Mutations in this gene are associated with the autosomal dominant Charcot-Marie-Tooth disease, type 1. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: CMT1D, CMT4E, DKFZp686J1957, FLJ14547, KROX20, AT591
Protein Interaction Partner: RPL7L1, HN1L, RIMKLB, RBM15B, NDUFS2, BPGM, SRA1, DTX1, WWP2, UBC, UBE2I, NAB2, SOX8, MED31, SOX10, HCFC1, ACP5, NFATC1, FASLG,
Protein Size: 476

Poids moléculaire: 50 kDa

ID gène: 1959

NCBI Accession: NM_000399, NP_000390

UniProt: P11161